Literature DB >> 11601975

Crystal structure of native chicken fibrinogen at 2.7 A resolution.

Z Yang1, J M Kollman, L Pandi, R F Doolittle.   

Abstract

The crystal structure of native chicken fibrinogen (320 kDa) complexed with two synthetic peptides has been determined at a resolution of 2.7 A. The structure provides the first atomic-resolution view of the polypeptide chain arrangement in the central domain where the two halves of the molecule are joined, as well as of a putative thrombin-binding site. The amino-terminal segments of the alpha and beta chains, including fibrinopeptides A and B, are not visible in electron density maps, however, and must be highly disordered. The alphaC domain is also very disordered. A residue by residue analysis of the coiled coils with regard to temperature factor shows a strong correlation between mobility and plasmin attack sites. It is concluded that structural flexibility is an inherent feature of fibrinogen that plays a key role in both its conversion to fibrin and its subsequent destruction by plasmin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11601975     DOI: 10.1021/bi011394p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  46 in total

1.  Substitution of the human αC region with the analogous chicken domain generates a fibrinogen with severely impaired lateral aggregation: fibrin monomers assemble into protofibrils but protofibrils do not assemble into fibers.

Authors:  Lifang Ping; Lihong Huang; Barbara Cardinali; Aldo Profumo; Oleg V Gorkun; Susan T Lord
Journal:  Biochemistry       Date:  2011-09-27       Impact factor: 3.162

2.  Crystal structure of the complex between thrombin and the central "E" region of fibrin.

Authors:  Igor Pechik; Joel Madrazo; Michael W Mosesson; Irene Hernandez; Gary L Gilliland; Leonid Medved
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

3.  Visualization and mechanical manipulations of individual fibrin fibers suggest that fiber cross section has fractal dimension 1.3.

Authors:  M Guthold; W Liu; B Stephens; S T Lord; R R Hantgan; D A Erie; R M Taylor; R Superfine
Journal:  Biophys J       Date:  2004-10-01       Impact factor: 4.033

4.  The structure of soluble fibrin oligomers.

Authors:  M A Rosenfeld; V B Leonova; M I Biryukova; M V Vasileva
Journal:  Dokl Biochem Biophys       Date:  2011-11-19       Impact factor: 0.788

5.  Structural hierarchy governs fibrin gel mechanics.

Authors:  Izabela K Piechocka; Rommel G Bacabac; Max Potters; Fred C Mackintosh; Gijsje H Koenderink
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

Review 6.  A comparison of the mechanical and structural properties of fibrin fibers with other protein fibers.

Authors:  M Guthold; W Liu; E A Sparks; L M Jawerth; L Peng; M Falvo; R Superfine; R R Hantgan; S T Lord
Journal:  Cell Biochem Biophys       Date:  2007-10-02       Impact factor: 2.194

7.  Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly.

Authors:  Igor Pechik; Sergiy Yakovlev; Michael W Mosesson; Gary L Gilliland; Leonid Medved
Journal:  Biochemistry       Date:  2006-03-21       Impact factor: 3.162

8.  Identification of an ordered compact structure within the recombinant bovine fibrinogen alphaC-domain fragment by NMR.

Authors:  Robert A Burton; Galina Tsurupa; Leonid Medved; Nico Tjandra
Journal:  Biochemistry       Date:  2006-02-21       Impact factor: 3.162

9.  NMR solution structure, stability, and interaction of the recombinant bovine fibrinogen alphaC-domain fragment.

Authors:  Robert A Burton; Galina Tsurupa; Roy R Hantgan; Nico Tjandra; Leonid Medved
Journal:  Biochemistry       Date:  2007-06-23       Impact factor: 3.162

10.  Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other.

Authors:  Rustem I Litvinov; Sergiy Yakovlev; Galina Tsurupa; Oleg V Gorkun; Leonid Medved; John W Weisel
Journal:  Biochemistry       Date:  2007-07-13       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.